Stopping pancreatic cancer before it starts

Where it stands as of Oct 14, 2026

Cancer interception is emerging as its own field, aimed at halting abnormal growths before they become tumours. In one vaccine trial, roughly 90 percent of participants with pancreatic abnormalities generated immune cells better able to recognize mutated cells. Whether that immune response prevents cancer in people is not yet known.